Travere Therapeutics (TVTX) Stock News

$TVTX · NASDAQ · 1 stories in 30 days

BORSA has published 1 story on Travere Therapeutics (TVTX) in the past 30 days. BORSA’s news read on TVTX is balanced at 50/100, unchanged over 24 hours, based on 1 company event over the past 7 days. Travere Therapeutics’ next earnings report is scheduled for Thursday, Oct 29.

The wire on $TVTX

newest first · updated Oct 12, 5:00 PM ET · direct subject stories only

CorporateOct 12 · 5:00 PM ET

Travere Therapeutics reports inducement grants for 33 new employees

Travere Therapeutics granted inducement equity covering 178,580 shares to 33 new employees, including stock options and RSUs, under Nasdaq Listing Rule 5635(c)(4).

neutral 50 · impact 10

Travere Therapeutics grants inducement equity to new employees, depicted as sprouts in a chest with a key.

← Stocks · in the newsroom

Travere Therapeutics (TVTX) Stock News

$TVTX · NASDAQ · 1 stories in 30 days

The wire on $TVTX

newest first · updated Oct 12, 5:00 PM ET · direct subject stories only

CorporateOct 12 · 5:00 PM ET

Travere Therapeutics reports inducement grants for 33 new employees

Travere Therapeutics granted inducement equity covering 178,580 shares to 33 new employees, including stock options and RSUs, under Nasdaq Listing Rule 5635(c)(4).

neutral 50 · impact 10

Frozen company-score outcomes

One recorded score per stock and trading day. Evidence and method are fixed before the measured returns. Later news cannot rewrite those predictions.

Horizon	Coverage	Vs SPY match	Vs sector match	Stock median	Vs SPY median	Vs sector median
1 hour	0 measured · 0 days · 0 pending · 4 unavailable	Collecting (0/30)	Collecting (0/30)	—	—	—
Next session close	0 measured · 0 days · 0 pending · 4 unavailable	Collecting (0/30)	Collecting (0/30)	—	—	—
Fifth subsequent session close	0 measured · 0 days · 0 pending · 4 unavailable	Collecting (0/30)	Collecting (0/30)	—	—	—

Method ticker-news-v4. Direction match appears only after 30 scored trading days per horizon. Neutral scores and benchmark moves within ±0.05% are unscored. Five-session outcomes overlap; observations are not independent trials. These are price returns, not dividend-reinvested returns. This is observation, not established predictive accuracy.

Travere Therapeutics (TVTX) Stock News

The wire on $TVTX

Travere Therapeutics (TVTX) Stock News

The wire on $TVTX

The wire on this name is open. What the tape did about it is one free account away.

Travere Therapeutics (TVTX) stock: common questions

What is the latest Travere Therapeutics stock news?

Is the news on TVTX bullish or bearish?

When does Travere Therapeutics report earnings?

Frozen company-score outcomes